Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses
J. Clin. Invest. Golo Ahlenstiel, et al. 118:1017
doi:10.1172/JCI32400 [Go to this article.]

Figure 4
HLA-C–inhibited NK cells of HLA-C1 homozygous subjects secrete IFN-γ more rapidly after IAV infection than do HLA-C–inhibited NK cells of HLA-C2 homozygous subjects. (A and C) Kinetic analysis of the IFN-γ response of (A) HLA-C–inhibited NK cells and (C) the total NK cell population for a subgroup of HLA-C1 and HLA-C2 homozygous subjects. The respective NK cell populations were identified in IAV-infected, CD3-depleted PBMCs in a cytokine-secretion assay by flow cytometry. Mean and SEM at each time point of the infection assay are shown relative to the study end point at 17 h (expressed as ratio). n = 5 per group. (B) Frequency of IFN-γ+, HLA-C–inhibited NK cells at the 9-h time point of the IAV assay relative to the 17-h time point (expressed as 9-h/17-h ratio). (D) IFN-γ released by the total NK cell population during the first 9h of the IAV assay relative to IFN-γ released during the total 17h of the IAV assay (set as 100%). Experiments in B and D were performed as in A, but included a larger number of HLA-C1 (n = 9) and HLA-C2 homozygous subjects (n = 8). Horizontal lines indicate the mean.